Functional signatures of de novo GABBR1 and GABBR2 variants associated with neurodevelopmental disorders
Michał Stawarski(Florida Atlantic University), Bernhard Bettler(Department of Biomedicine Basel)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABA<sub>B(1)</sub>‐deficient mice
|European Journal of Neuroscience|2003|184
The Anticonvulsant Gabapentin (Neurontin) Does Not Act through γ-Aminobutyric Acid-B Receptors
|Molecular Pharmacology|2002|107